<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01076049</url>
  </required_header>
  <id_info>
    <org_study_id>108527</org_study_id>
    <nct_id>NCT01076049</nct_id>
  </id_info>
  <brief_title>Evaluation of IrriSept for Irrigation of Skin and Soft Tissue Infections in the Emergency Room Setting</brief_title>
  <acronym>USF</acronym>
  <official_title>Evaluation of a Novel Solution, IrriSept, Containing a Long-Acting Antimicrobial Agent for Irrigation of Skin and Soft Tissue Infections in the Emergency Setting</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Irrimax Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Irrimax Corporation</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Does irrigation with IrriSept prevent infected wound progression when compared to usual care?
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    suboptimal recruitment
  </why_stopped>
  <start_date>December 2009</start_date>
  <completion_date type="Actual">April 2013</completion_date>
  <primary_completion_date type="Actual">April 2013</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>State of wound</measure>
    <time_frame>48 hours</time_frame>
    <description>physician assessment of wound at 48 hours - either as cured, improved, no change or progression</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Methicillin-resistant Staphylococcus aureus (MRSA) colonisation Rate</measure>
    <time_frame>48 hours</time_frame>
    <description>rates of MRSA nares colonisation
subjective measures of discomfort/pain</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">114</enrollment>
  <condition>Non-complicated Skin and Soft Tissue Infections</condition>
  <arm_group>
    <arm_group_label>Standard Care</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>purely observes standard operation of ER doctor</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Irrisept Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>observation of SOP</intervention_name>
    <description>standard treatment of infection</description>
    <arm_group_label>Standard Care</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>IrriSept Irrigation</intervention_name>
    <description>irrigation of the wound using IrriSept</description>
    <arm_group_label>Irrisept Arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18 to 80.

          -  SSTls, including abscesses, cutaneous surgical site infections, infected wounds, etc.

          -  Patient able to provide an informed consent.

          -  Patient volunteers to participate.

        Exclusion Criteria:

          -  Wound was caused by human or animal bite.

          -  Wound is a blunt crush injury or has tendon, bone or joint involvement.

          -  Diabetic foot infection.

          -  Admission to hospital for any reason, including IV antibiotics.

          -  Clinical signs of systemic infection on initial patient encounter.

          -  Prior history of allergy or hypersensitivity to CHG.

          -  Neutropenia (known ANC&lt;500/mm3), HIV (known CD4&lt;50), or other severely
             immunocompromised state (e.g. receiving chemotherapy).

          -  Pt is diagnosed with systemic lupus erythematosus or other immunological disease.

          -  Patient withdraws from participation.

          -  Patient unable or unwilling to give informed consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Erin Stirling</last_name>
    <role>Principal Investigator</role>
    <affiliation>University South Florida</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of South Florida</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33606</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 23, 2010</study_first_submitted>
  <study_first_submitted_qc>February 24, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 25, 2010</study_first_posted>
  <last_update_submitted>June 12, 2013</last_update_submitted>
  <last_update_submitted_qc>June 12, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 14, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Emergencies</mesh_term>
    <mesh_term>Soft Tissue Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

